Ophthalmic firm Komi applies for stock exchange listing on strong revenue growth

Komi Instrument, a Taiwanese manufacturer of ophthalmic equipment, has applied to list on the Taipei Exchange, according to an announcement on July 9. The company reported June revenue of 91.92 million New Taiwan dollars, a 9% increase month-on-month and a 30.8% rise year-on-year, marking its second-highest revenue month on record. For the first half of the year, cumulative revenue reached 380 million New Taiwan dollars, up 5.96% from the previous year.

The revenue growth is attributed to a significant increase in installed equipment compared to last year, contributing tens of millions in revenue. Additionally, sales of femtosecond cataract consumables rose 29% in June year-on-year, with a 17% increase year-to-date. The increasing adoption of high-priced trifocal intraocular lenses also boosted overall sales, demonstrating steady growth across multiple business segments.

Komi Instrument's chairman, Chiang Chin-hsien, highlighted that Taiwan's annual cataract surgeries number around 300,000, with demand steadily growing as the nation ages. The company commands over 40% of the femtosecond cataract market in Taiwan, positioning it as the largest supplier of cataract surgery equipment in the country. Through a combination of leasing and revenue-sharing models, Komi Instrument stimulates both surgical volume and consumable sales. The company anticipates further growth in the second half of the year as its product line expands.

Looking ahead, Komi Instrument plans to introduce new products in the latter half of the year. By the fourth quarter, the company aims to enter the short-delay focus market. It will also launch implantable contact lenses and home eye pressure monitors, addressing the needs of the high myopia market and expanding its eye pressure measurement business channels. This strategic move will complete its product line, covering everything from the cornea to the interior of the eye.

“

The revenue growth comes from an increase in installed equipment this year compared to last year, contributing tens of millions in revenue, and sales of femtosecond cataract consumables increased by 29% year-on-year in June, with a cumulative increase of 17% since the beginning of the year, coupled with the continuous improvement of the penetration rate of high-priced trifocal intraocular lenses, with multiple businesses growing simultaneously.